$7.64
-0.01-0.13%
At close: -
Comments
Loading...
Neuberger Berman High Analyst Ratings and Price Targets | AMEX:NHS | Benzinga
Neuberger Berman High Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Neuberger Berman High Corp from these most-recent analyst ratings.
Analyst Ratings for Neuberger Berman High
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Neuberger Berman High (NHS) stock?
There is no price target for Neuberger Berman High
What is the most recent analyst rating for Neuberger Berman High (NHS)?
There is no analyst for Neuberger Berman High
When was the last upgrade for Neuberger Berman High (NHS)?
There is no last upgrade for Neuberger Berman High
When was the last downgrade for Neuberger Berman High (NHS)?
There is no last downgrade for Neuberger Berman High.
When is the next analyst rating going to be posted or updated for Neuberger Berman High (NHS)?
There is no next analyst rating for Neuberger Berman High.
Is the Analyst Rating Neuberger Berman High (NHS) correct?
There is no next analyst rating for Neuberger Berman High.
Browse analyst ratings and price targets on all stocks.